Sutro Biopharma, Inc. (STRO)
12.64
+2.01
(+18.91%)
USD |
NASDAQ |
Jan 14, 16:00
12.64
0.00 (0.00%)
After-Hours: 17:50
Sutro Biopharma Research and Development Expense (Annual): 252.04M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| GT Biopharma, Inc. | 5.798M |
| Daré Bioscience, Inc. | 14.21M |
| Syndax Pharmaceuticals, Inc. | 241.64M |
| Crinetics Pharmaceuticals, Inc. | 237.37M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |